67 results
8-K
EX-10.3
OCUL
Ocular Therapeutix Inc
22 Feb 24
Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
7:34am
Department: law@ocutx.com
If to the Company:
Dr. Pravin Dugel
Address on File with the Company
With an email copy to:
Michael S. Katzke
8-K
EX-99.1
OCUL
Ocular Therapeutix Inc
14 Dec 23
Ocular TherapeutixTM Announces Pricing of Public Offering of Common Stock
8:46am
, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone: (877) 821-7388, or by email … : prospectus_department@Jefferies.com; BofA Securities, Attention: Prospectus Department, NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, or by email
8-K
EX-1.1
OCUL
Ocular Therapeutix Inc
14 Dec 23
Ocular TherapeutixTM Announces Pricing of Public Offering of Common Stock
8:46am
of any sanctions administered or enforced by the U.S. Department of Treasury’s Office of Foreign Assets Control, the United Nations Security Council … Park
New York, New York 10036
Email: dg.ecm_execution_services@bofa.com
Attention: Syndicate Department
with a copy to:
Email: dg.ecm_legal
8-K
EX-99.1
j20tis5sw2pp0em5mpeo
8 Nov 21
Ocular Therapeutix™ Reports Third Quarter 2021 Financial Results and Business Update
4:04pm
8-K
EX-1.1
upuc7qng0
9 Aug 21
Entry into a Material Definitive Agreement
4:48pm
8-K
EX-10.1
xrcgn07z6sgc3xtq qmu
4 Jun 21
Entry into a Material Definitive Agreement
4:34pm